FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kentaro Yamazaki

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Chemicals & Drugs

Disorders

Physiology

Drug Resistance, Neoplasm

Co-author Network

Publications

TOP 3
Nozomu Machida; Yusuke Onozawa; Narikazu Boku; Akira Fukutomi; Kentaro Yamazaki; Hirofumi Yasui; Kouji Yoshizaki; Keisei Taku
Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients.
Takahiro Tsushima; Kentaro Yamazaki; Hirofumi Yasui; Hiroya Taniguchi; Akiko Todaka; Narikazu Boku; Akira Fukutomi; Shuichi Hironaka; Nozomu Machida; Yusuke Onozawa; Keisei Taku
Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer.
Hideharu Tomita; Kentaro Yamazaki; Hirofumi Yasui; Narikazu Boku; Akira Fukutomi; Nozomu Machida; Koichi Mitsuya; Yoko Nakasu; Yusuke Onozawa; Keisei Taku; Hiroya Taniguchi; Akiko Todaka; Takahiro Tsushima
Leptomeningeal carcinomatosis associated with gastric cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kentaro Yamazaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nozomu Machida; Yusuke Onozawa; Narikazu Boku; Akira Fukutomi; Kentaro Yamazaki; Hirofumi Yasui; Kouji Yoshizaki; Keisei Taku
Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients.
International journal of clinical oncology 2013;18(2):279-84.
2013: Takahiro Tsushima; Kentaro Yamazaki; Hirofumi Yasui; Hiroya Taniguchi; Akiko Todaka; Narikazu Boku; Akira Fukutomi; Shuichi Hironaka; Nozomu Machida; Yusuke Onozawa; Keisei Taku
Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer.
International journal of clinical oncology 2013;18(1):10-6.
2012: Hideharu Tomita; Kentaro Yamazaki; Hirofumi Yasui; Narikazu Boku; Akira Fukutomi; Nozomu Machida; Koichi Mitsuya; Yoko Nakasu; Yusuke Onozawa; Keisei Taku; Hiroya Taniguchi; Akiko Todaka; Takahiro Tsushima
Leptomeningeal carcinomatosis associated with gastric cancer.
International journal of clinical oncology 2012;17(4):361-6.
2012: Hiroto Ishiki; Takashi Kojima; Nozomu Machida; Narikazu Boku; Akira Fukutomi; Takayuki Hashimoto; Shuichi Hironaka; Yusuke Onozawa; Keisei Taku; Kentaro Yamazaki; Hirofumi Yasui; Tetsuo Nishimura
Nutrition support for head and neck squamous cell carcinoma patients treated with chemoradiotherapy: how often and how long?
ISRN oncology 2012;2012():274739.
2011: Hiroya Taniguchi; Akiko Todaka; Hideharu Tomita; Yasuhiro Tsubosa; Takahiro Tsushima; Kentaro Yamazaki; Narikazu Boku; Akira Fukutomi; Taro Funakoshi; Satoshi Hamauchi; Nozomu Machida; Tetsuo Nishimura; Yusuke Onozawa; Takeshi Sakamoto; Hiroshi Sato; Keisei Taku; Hirofumi Yasui
Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta.
International journal of clinical oncology 2011;16(4):359-65.
2010: Takahiro Tsushima; Shuichi Hironaka; Narikazu Boku; Nozomu Machida; Kentaro Yamazaki; Hirofumi Yasui; Keisei Taku; Akira Fukutomi; Yusuke Onozawa
Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2010;13(4):245-50.
2010: Takeshi Sakamoto; Hirofumi Yasui; Narikazu Boku; Yusuke Onozawa; Shuichi Hironaka; Akira Fukutomi; Kentaro Yamazaki; Keisei Taku; Nozomu Machida; Akiko Todaka; Hideharu Tomita; Takahiro Tsushima; Hiroya Taniguchi; Satoshi Hamauchi
Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis.
International journal of clinical oncology 2010;15(3):287-93.
2010: Akiko Todaka; Akira Fukutomi; Narikazu Boku; Yusuke Onozawa; Shuichi Hironaka; Hirofumi Yasui; Kentaro Yamazaki; Keisei Taku; Nozomu Machida; Takeshi Sakamoto; Hideharu Tomita
S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure.
Japanese journal of clinical oncology 2010;40(6):567-72.
2009: Akihiro Tamiya; Kentaro Yamazaki; Narikazu Boku; Nozomu Machida; Takashi Kojima; Keisei Taku; Hirofumi Yasui; Akira Fukutomi; Shuichi Hironaka; Yusuke Onozawa
Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer: a retrospective review of 65 Japanese patients.
International journal of clinical oncology 2009;14(6):513-7.
2009: Hirofumi Yasui; Takayuki Yoshino; Narikazu Boku; Yusuke Onozawa; Shuichi Hironaka; Akira Fukutomi; Kentaro Yamazaki; Keisei Taku; Takashi Kojima; Nozomu Machida
Retrospective analysis of S-1 monotherapy in patients with metastatic colorectal cancer after failure to fluoropyrimidine and irinotecan or to fluoropyrimidine, irinotecan and oxaliplatin.
Japanese journal of clinical oncology 2009;39(5):315-20.
2009: Akira Ono; Narikazu Boku; Yusuke Onozawa; Shuichi Hironaka; Akira Fukutomi; Hiroshi Yasui; Kentaro Yamazaki; Takayuki Yoshino; Keisei Taku; Takashi Kojima
Activity of S-1 in advanced or recurrent gastric cancer patients after failure of prior chemotherapy, including irinotecan + cisplatin or fluorouracil (except S-1).
Japanese journal of clinical oncology 2009;39(5):332-5.
2009: Rai Shimoyama; Hirofumi Yasui; Narikazu Boku; Yusuke Onozawa; Shuichi Hironaka; Akira Fukutomi; Kentaro Yamazaki; Keisei Taku; Takashi Kojima; Nozomu Machida; Akiko Todaka; Hideharu Tomita; Takeshi Sakamoto; Takahiro Tsushima
Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2009;12(4):206-11.
2009: Masako Imazawa; Takashi Kojima; Narikazu Boku; Yusuke Onozawa; Shuichi Hironaka; Akira Fukutomi; Hirofumi Yasui; Kentaro Yamazaki; Keisei Taku
Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2009;12(3):153-7.
2008: Koji Nakashima; Shuichi Hironaka; Narikazu Boku; Yusuke Onozawa; Akira Fukutomi; Kentaro Yamazaki; Hirofumi Yasui; Keisei Taku; Takashi Kojima; Nozomu Machida
Irinotecan plus cisplatin therapy and S-1 plus cisplatin therapy for advanced or recurrent gastric cancer in a single institution.
Japanese journal of clinical oncology 2008;38(12):810-5.
2008: Nozomu Machida; Takayuki Yoshino; Narikazu Boku; Shuichi Hironaka; Yusuke Onozawa; Akira Fukutomi; Kentaro Yamazaki; Hirofumi Yasui; Keisei Taku; Masahiro Asaka
Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancer.
Japanese journal of clinical oncology 2008;38(10):689-94.
2008: Koji Nakashima; Kentaro Yamazaki; Narikazu Boku
[Molecular target therapy and chemotherapy for advanced colorectal cancer].
Gan to kagaku ryoho. Cancer & chemotherapy 2008;35(5):725-30.
2008: Kentaro Yamazaki; Shuichi Hironaka; Narikazu Boku; Hirofumi Yasui; Akira Fukutomi; Takayuki Yoshino; Yusuke Onozawa; Noriaki Hasuike; Tetsuya Inui; Yuichiro Yamaguchi; Hiroyuki Ono
A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.
International journal of clinical oncology 2008;13(2):150-5.
2008: Koichi Taira; Narikazu Boku; Akira Fukutomi; Yusuke Onozawa; Shuichi Hironaka; Takayuki Yoshino; Hirofumi Yasui; Kentaro Yamazaki; Keisei Taku; Takayuki Hashimoto; Tetsuo Nishimura
Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer.
Journal of gastroenterology 2008;43(11):875-80.
2008: Sadamoto Zenda; Shuichi Hironaka; Narikazu Boku; Kentaro Yamazaki; H Yasui; Akira Fukutomi; Takayuki Yoshino; Yusuke Onozawa; Tetsuo Nishimura
Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E 2008;21(3):195-200.
2007: Takayuki Yoshino; Narikazu Boku; Yusuke Onozawa; Shuichi Hironaka; Akira Fukutomi; Yuichiro Yamaguchi; Noriaki Hasuike; Kentaro Yamazaki; Nozomu Machida; Hiroyuki Ono
Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Japanese journal of clinical oncology 2007;37(9):686-91.
2007: Kentaro Yamazaki; Takayuki Yoshino; Narikazu Boku
[Bevacizumab (Avastin)].
Gan to kagaku ryoho. Cancer & chemotherapy 2007;34(8):1183-91.
2007: Kentaro Yamazaki; Narikazu Boku; Kaoru Shibamoto; Hirofumi Yasui; Akira Fukutomi; Takayuki Yoshino; Shuichi Hironaka; Yusuke Onozawa; Yosuke Otake; Noriaki Hasuike; Hiroyuki Matsubayashi; Tetsuya Inui; Yuichiro Yamaguchi; Hiroyuki Ono
The role of the outpatient clinic in chemotherapy for patients with unresectable or recurrent gastric cancer.
Japanese journal of clinical oncology 2007;37(2):96-101.
2006: Kentaro Yamazaki; Takayuki Yoshino; Narikazu Boku
[IFL].
Gan to kagaku ryoho. Cancer & chemotherapy 2006;33(7):907-10.
2005: Masaki Matsuoka; Narikazu Boku; Takayuki Yoshino; Shuichi Hironaka; Yusuke Onozawa; Akira Fukutomi; Sadamoto Zenda; Kentaro Yamazaki; Hirofumi Yasui; Noriaki Hasuike; Tetsuya Inui; Yuichiro Yamaguchi; Hiroyuki Ono; Minoru Kamata
Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel.
International journal of clinical oncology 2005;10(6):429-32.